These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21838521)

  • 1. Pseudomonas aeruginosa growth in Refresh Plus®.
    Pinna A; Usai D; Zanetti S
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):561-4. PubMed ID: 21838521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.
    Albietz JM; Lenton LM; McLennan SG; Earl ML
    CLAO J; 2002 Apr; 28(2):96-100. PubMed ID: 12054380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased incidence of epithelial defects during laser in situ keratomileusis using intraoperative nonpreserved carboxymethylcellulose sodium 0.5% solution.
    Ahee JA; Kaufman SC; Samuel MA; Bogorad D; Wee C
    J Cataract Refract Surg; 2002 Sep; 28(9):1651-4. PubMed ID: 12231327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
    Rosenthal RA; Buck SL; Henry CL; Schlech BA
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro.
    Huang LC; Jean D; McDermott AM
    Eye Contact Lens; 2005 Jan; 31(1):34-8. PubMed ID: 15665670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
    Ousler GW; Michaelson C; Christensen MT
    Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition of artificial tear solution affects in vitro Pseudomonas aeruginosa biofilm formation on silicone hydrogel lens.
    Yadav MK; Chuck RS; Park CY
    J Ocul Pharmacol Ther; 2013; 29(6):591-4. PubMed ID: 23442006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurotrophic keratopathy--a post-LASIK case report].
    Fuchsluger TA; Steuhl KP; Meller D
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):901-4. PubMed ID: 16308823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of artificial tears on visual acuity.
    Nilforoushan MR; Latkany RA; Speaker MG
    Am J Ophthalmol; 2005 Nov; 140(5):830-5. PubMed ID: 16310460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
    Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
    Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia.
    Alfawaz AM; Algehedan S; Jastaneiah SS; Al-Mansouri S; Mousa A; Al-Assiri A
    Curr Eye Res; 2014 Mar; 39(3):257-62. PubMed ID: 24147767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas keratitis 4 years after laser in situ keratomileusis.
    Ferrer C; Rodriguez-Prats JL; Abad JL; Claramonte P; Alió JL; Signes-Soler I
    Optom Vis Sci; 2011 Oct; 88(10):1252-4. PubMed ID: 21666521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic dry eye and regression after laser in situ keratomileusis for myopia.
    Albietz JM; Lenton LM; McLennan SG
    J Cataract Refract Surg; 2004 Mar; 30(3):675-84. PubMed ID: 15050267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the use of preservative-free topicals.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LASIK and dry eye.
    Toda I
    Compr Ophthalmol Update; 2007; 8(2):79-85; discussion 87-9. PubMed ID: 17540125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Microbial Contamination in Multiple-Dose Preservative-Free Ophthalmic Preparations.
    Saisyo A; Shimono R; Oie S; Kimura K; Furukawa H
    Biol Pharm Bull; 2017; 40(2):182-186. PubMed ID: 28154258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of laser-in-situ-keratomileusis.
    Sridhar MS; Rao SK; Vajpayee RB; Aasuri MK; Hannush S; Sinha R
    Indian J Ophthalmol; 2002 Dec; 50(4):265-82. PubMed ID: 12532491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leukemia inhibitory factor on corneal nerve regeneration of rabbit eyes after laser in situ keratomileusis.
    Pan S; Li L; Xu Z; Zhao J
    Neurosci Lett; 2011 Jul; 499(2):99-103. PubMed ID: 21640792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.